1 / 16

Implications of C. difficile diagnostic testing

Implications of C. difficile diagnostic testing. Not seeing the wood for the trees Warren Lowman Pathlink / Vermaak & Partners Pathologists Wits Donald Gordon Medical Centre Clinical Microbiology & Infectious Diseases, University of the Witwatersrand. Pubmed & C. difficile. 9298 hits

cameron-kennedy
Télécharger la présentation

Implications of C. difficile diagnostic testing

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Implications of C. difficile diagnostic testing Not seeing the wood for the trees Warren Lowman Pathlink/ Vermaak & Partners Pathologists Wits Donald Gordon Medical Centre Clinical Microbiology & Infectious Diseases, University of the Witwatersrand

  2. Pubmed & C. difficile • 9298 hits • + Clinical trials = 330 • + Diagnosis = 169 • + Testing = 20

  3. Clinical relevance… 2 key issues that are largely ignored: • Pre-test probability • PPV

  4. Are we selecting accurately? 67.1 tests/ 10 000 pt bed days (range, 29 – 153)

  5. C. difficile diagnostics… • We are floundering- survey of UK labs indicate >25 different algorithms • Multitude of different assays • Impacts on our understanding of the epidemiology of CDI.

  6. The “best” study Lancet Infect Dis 2013 Diagnostic assays Study design Clinical data

  7. Salient points • Tested all faecal samples irrespective of request • Wide scope of practice • Detection of 3 targets: bacterium; toxin; gene • Predefined groups: diagnostic; severity • Statistically very “sound” • Diagnostic performance assessed in training phase

  8. Clinical relevance by assay • Data for 6522 inpatient episodes

  9. …clinical relevance by assay • Same comparison using PCR as surrogate for cytotoxigenic culture

  10. The point…clinically

  11. So what do we do about diagnosis?

  12. What’s best?

  13. The implications CLINICAL OUTCOME MANAGEMENT TOXIN POSITIVITY DIAGNOSTIC ASSAY

  14. C. difficile excretors…an issue? Overtreatment…excessive antibiotic use! Cost…this all adds up

  15. 3-stage algorithm Not CDAD GDH CDAD EIA Toxin 8% NAAT Not CDAD C. difficile excretor

  16. Thank you!

More Related